Leon Raskin
Faculty Member
Last active: 5/20/2014

  1. Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. Raskin L, Fullen DR, Giordano TJ, Thomas DG, Frohm ML, Cha KB, Ahn J, Mukherjee B, Johnson TM, Gruber SB (2013) J Invest Dermatol 133(11): 2585-2592
    › Primary publication · 23633021 (PubMed) · PMC4267221 (PubMed Central)
  2. Interaction of fatty acid genotype and diet on changes in colonic fatty acids in a Mediterranean diet intervention study. Porenta SR, Ko YA, Gruber SB, Mukherjee B, Baylin A, Ren J, Djuric Z (2013) Cancer Prev Res (Phila) 6(11): 1212-21
    › Primary publication · 24022589 (PubMed) · PMC3840911 (PubMed Central)
  3. Distinct molecular features of colorectal cancer in Ghana. Raskin L, Dakubo JC, Palaski N, Greenson JK, Gruber SB (2013) Cancer Epidemiol 37(5): 556-61
    › Primary publication · 23962701 (PubMed) · PMC4267222 (PubMed Central)
  4. Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers. Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB, GEM Study Investigators (2012) J Natl Cancer Inst 104(12): 953-6
    › Primary publication · 22534780 (PubMed) · PMC3379723 (PubMed Central)
  5. A pilot study of microsatellite instability and endometrial cancer survival in white and African American women. Cote ML, Kam A, Chang CY, Raskin L, Reding KW, Cho KR, Gruber SB, Ali-Fehmi R (2012) Int J Gynecol Pathol 31(1): 66-72
    › Primary publication · 22123725 (PubMed)
  6. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, Mukherjee B, Iniesta MD, Morgan MA, Rennert G, Gruber SB (2011) Cancer Res 71(7): 2632-42
    › Primary publication · 21300766 (PubMed) · PMC3407272 (PubMed Central)
  7. Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, Gruber SB (2011) Cancer Epidemiol Biomarkers Prev 20(3): 522-9
    › Primary publication · 21307304 (PubMed) · PMC3833711 (PubMed Central)
  8. Copy number variations and clinical outcome in atypical spitz tumors. Raskin L, Ludgate M, Iyer RK, Ackley TE, Bradford CR, Johnson TM, Fullen DR (2011) Am J Surg Pathol 35(2): 243-52
    › Primary publication · 21263245 (PubMed)
  9. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod SA, Levine DA, Bogomolniy F, Aronson M, Thibodeau SN, Hunt KS, Rennert G, Gallinger S, Gruber SB, Foulkes WD (2011) Clin Genet 79(6): 512-22
    › Primary publication · 21155762 (PubMed) · PMC4541773 (PubMed Central)
  10. Returning individual research results: development of a cancer genetics education and risk communication protocol. Roberts JS, Shalowitz DI, Christensen KD, Everett JN, Kim SY, Raskin L, Gruber SB (2010) J Empir Res Hum Res Ethics 5(3): 17-30
    › Primary publication · 20831418 (PubMed) · PMC3159194 (PubMed Central)